Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function

Toxicology

Volumn 270, Issue 2-3, 2010, Pages 99-105

  Custódio, José B A ^a   Santos, Maria S ^a   Gonçalves, Dália I R ^a   Moreno, António J M ^b   Fernandes, Eduarda ^c   Bastos, Maria L ^c   Carvalho, Félix ^c   Vicente, Joaquim A F ^b   Fernandes, Maria A S ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

3,4 Methylenedioxymethamphetamine (ecstasy; 4 Methylthioamphetamine (MTA); Amphetamine derivatives; Liver mitochondria; MDMA); Mitochondrial bioenergetics; Mitochondrial function; Mitochondrial permeability transition

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 4 METHYLTHIOAMPHETAMINE; AMINE OXIDASE (FLAVIN CONTAINING); AMPHETAMINE DERIVATIVE; HYDROGEN PEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOENERGY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; LIVER MITOCHONDRION; LIVER TOXICITY; MALE; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

RATTUS;

EID: 77950021914     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.01.022     Document Type: Article

References (64)

1. Alves E., Summavielle T., Alves C.J., Gomes-da-Silva J., Barata J.C., Fernandes E., Bastos M.L., Tavares M.A., Carvalho F. Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria. J. Neurosci. 2007, 27:10203-10210.
2. Alves E., Summavielle T., Alves C.J., Custódio J.B., Fernandes E., de Lourdes B.M., Tavares M.A., Carvalho F. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A. Addict. Biol. 2009, 14:185-193.
3. Andreu V., Mas A., Bruguera M., Salmero J.M., Moreno V., Nogué S., Rodes J. Ecstasy: a common cause of severe acute hepatotoxicity. J. Hepatol. 1998, 29:394-397.
4. 2 generation in isolated mitochondria. J. Bioenerg. Biomembr. 2002, 34:227-233.
5. Beitia G., Cobreros A., Sainz L., Cenarruzabeitia E. 3,4-Methlylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity. Effect on cytosolic calcium signals in isolated hepatocytes. Liver 1999, 19:234-241.
6. Beitia G., Cobreros A., Sainz L., Cenarruzabeitia E. Ecstasy-induced toxicity in rat liver. Liver 2000, 8-15.
7. Belizário J.E., Alves J., Occhiucci J.M., Garay-Malpartida M., Sesso A. A mechanistic view of mitochondrial death decision pores. Braz. J. Med. Biol. Res. 2007, 40:1011-1024.
8. Broekemeier K.M., Dempsey M.E., Pfeiffer D.R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 1989, 264:7826-7830.
9. Brown J.M., Yamamoto B.K. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol. Ther. 2003, 99:45-53.
10. Burgess C., O'Donohoe A., Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. Eur. Psychiatry 2000, 15:287-294.
11. Capela J.P., Fernandes E., Remião F., Bastos M.L., Meisel A., Carvalho F. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons. Neurotoxicology 2007, 28:868-875.
12. Capela J.P., Macedo C., Branco P.S., Ferreira L.M., Lobo A.M., Fernandes E., Remião F., Bastos M.L., Dirnagl U., Meisel A., Carvalho F. Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience 2007, 146:1743-1757.
13. Capela J.P., Carmo H., Remião F., Bastos M.L., Meisel A., Carvalho F. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol. Neurobiol. 2009, 39:210-271.
14. Cardoso C.M.P., Almeida L.M., Custódio J.B.A. Protection of tamoxifen against oxidation of mitochondrial thiols and NAD(P)H underlying the permeability transition induced by prooxidants. Chem. Biol. Interact. 2004, 148:149-161.
15. Carmo H., Remião F., Carvalho F., Fernandes E., de Boer D., dos Reys L.A., Bastos M.L. 4-Methylthioamphetamine-induced hyperthermia in mice: influence of serotonergic and catecholaminergic pathways. Toxicol. Appl. Pharmacol. 2003, 190:262-271.
16. Carmo H., Hengstler J.G., de Boer D., Ringel M., Carvalho F., Fernandes E., Remião F., dos Reys L.A., Oesch F., Bastos M.L. Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse. Naunyn-Schmiedebergs Arch. Pharmacol. 2004, 369:198-205.
17. Carvalho M., Carvalho F., Bastos M.L. Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes. Arch. Toxicol. 2001, 74:789-793.
18. Carvalho M., Milhazes N., Remião F., Borges F., Fernandes E., Amado F., Monks T.J., Carvalho F., Bastos M.L. Hepatotoxicity of 3,4-methylenedioxymethamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch. Toxicol. 2004, 78:16-24.
19. Cohen R.S. Subjective reports on the effects of the MDMA ('ecstasy') experience in humans. Prog. Neuropsychopharmacol. Biol. Psychiatry 1995, 19:1137-1145.
20. Costantini P., Chernyak B.V., Petronilli V., Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 1996, 271:6746-6751.
21. Costantini P., Colonna R., Bernardi P. Induction of the mitochondrial permeability transition by N-ethylmaleimide depends on secondary oxidation of critical thiol groups. Potentiation by copper-ortho-phenanthroline without dimerization of the adenine nucleotide translocase. Biochim. Biophys. Acta 1998, 1365:385-392.
22. Custódio J.B.A., Almeida L.M., Madeira V.M.C. Tamoxifen and hidroxitamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochim. Pharmacol. 1994, 47:1989-1998.
23. 2+ and inorganic phosphate. Toxicol. Appl. Pharmacol. 1998, 152:10-17.
24. De Boer D., Egberts T., Maes R.A. Para-methylthioamphetamine, a new amphetamine designer drug of abuse. Pharm. World Sci. 1999, 21:47-48.
25. Decaestecker T., De Letter E., Clauwaert K., Bouche M.P., Lambert W., Van Bocxlaer J., Piette M., Van den Eeckhout E., Van Peteghem C., De Leenheer A. Fatal MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices. J. Anal. Toxicol. 2001, 25:705-7110.
26. De Letter E.A., Coopman V.A., Cordonnier J.A., Piette M.H. One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings. Int. J. Legal Med. 2001, 114:352-356.
27. De Letter E.A., Bouche M.P., Van Bocxlaer J.F., Lambert W.E., Piette M.H. Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities. Forensic Sci. Int. 2004, 141:85-90.
28. Di Lisa F., Kaludercic N., Carpi A., Menabò R., Giorgio M. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66Shc and monoamine oxidase. Basic Res. Cardiol. 2009, 104:131-139.
29. Di Lisa F., Kaludercic N., Carpi A., Menabò R., Giorgio M. Mitochondria and vascular pathology. Pharmacol. Rep. 2009, 61:123-130.
30. Dykens J.A., Will Y. The significance of mitochondrial toxicity testing in drug development. Drug Discov. Today 2007, 12:777-785.
31. Elliott S.P. Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA). J. Anal. Toxicol. 2000, 24:85-89.
32. Elliott S.P. Analysis of 4-methylthioamphetamine in clinical specimens. Ann. Clin. Biochem. 2001, 38:339-347.
33. Ellis A.J., Wendon J.A., Portmann B., Williams R. Acute liver damage and ecstasy ingestion. Gut 1996, 38:454-458.
34. Gornall G., Bardawill C.J., David M.M. Determination of serum proteins by means of the Biuret reaction. J. Biol. Chem. 1949, 177:751-766.
35. Halestrap A.P., Woodfield K.Y., Connern C.P. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J. Biol. Chem. 1997, 272:3346-3354.
36. Hall A.P., Henry J.A. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br. J. Anaesth. 2006, 96:678-685.
37. Henry J.A., Jeffreys K.J., Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (" ecstasy" ). Lancet 1992, 340:384-387.
38. Hurtado-Guzmán C., Martínez-Alvarado P., Dagnino-Subiabre A., Paris I., Caviedes P., Caviedes R., Cassels B.K., Segura-Aguilar J. Neurotoxicity of some MAO inhibitors in adult rat hypothalamic cell culture. Neurotox. Res. 2002, 4:161-163.
39. Irvine R.J., Keane M., Felgate P., McCann U.D., Callaghan P.D., White J.M. Plasma drug concentrations and physiological measures in " dance party" participants. Neuropsychopharmacology 2006, 31:424-430.
40. Kamo N., Muratsugu M., Hongoh R., Kobatak N. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenylphosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J. Membr. Biol. 1979, 49:105-121.
41. Kirkbride K.P., Ward A.D., Jenkins N.F., Klass G., Coumbaros J.C. Synthesis of 4-methyl-5-arylpyrimidines and 4-arylpyrimidines: route specific markers for Leuckardt preparation of amphetamine, 4-methoxyamphetamine, and 4-methylthioamphetamine. Forensic Sci. Int. 2001, 115:53-67.
42. McStay G.P., Clarke S.J., Halestrap A.P. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem. J. 2002, 367:542-548.
43. Montiel-Duarte C., Varela-Rey M., Osés-Prieto J.A., López-Zabalza M.J., Beitia G., Cenarruzabeitia E., Iraburu M.J. 3,4-Methylenedioxymethamphetamine (ecstasy) induces apoptosis of cultured rat liver cells. Biochem. Biophys. Acta 2002, 1588:26-32.
44. Montiel-Duarte C., Ansorena E., López-Zabalza M.J., Cenarruzabeitia E., Iraburu M.J. Role of reactive oxygen species, glutathione and NF-kB in apoptosis induced by 3,4-methylenedioxymethamphetamine (ecstasy) on hepatic stellate cells. Biochem. Pharmacol. 2004, 67:1025-1033.
45. Moon K.-H., Upreti V.V., Yu L.-R., Lee I.J., Ye X., Eddington N.D., Veenstra T.D., Song B.-J. Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics 2008, 8:3906-3918.
46. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
47. Nakagawa Y., Suzuki T., Kamimura H., Nagai F. N-Nitrosofenfluramine induces cytotoxicity via mitochondrial dysfunction and oxidative stress in isolated rat hepatocytes. Arch. Toxicol. 2005, 79:312-320.
48. Nakagawa Y., Suzuki T., Tayama S., Ishii H., Ogata A. Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes. Arch. Toxicol. 2009, 83:69-80.
49. Neustadt J., Pieczenik S.R. Medication-induced mitochondrial damage and disease. Mol. Nutr. Food Res. 2008, 52:780-788.
50. O'Rourke B., Cortassa s., Aon M.A. Mitochondrial ion channels: gatekeepers of life and death. Physiology 2007, 20:303-315.
51. Orrenius S., Gogvadze V., Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu. Rev. Pharmacol. Toxicol. 2007, 47:143-148.
52. Pontes H., Duarte J.A., de Pinho P.G., Soares M.E., Fernandes E., Dinis-Oliveira R.J., Sousa C., Silva R., Carmo H., Casal S., Remião F., Carvalho F., Bastos M.L. Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice. Toxicology 2008, 252:64-71.
53. Pontes H., Sousa C., Silva R., Fernandes E., Carmo H., Remião F., Carvalho F., Bastos M.L. Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes. Toxicology 2008, 254:42-50.
54. Pontes H., Santos-Marques M.J., Fernandes E., Duarte J.A., Remião F., Carvalho F., Bastos M.L. Effect of chronic ethanol exposure on the hepatotoxicity of ecstasy in mice: an ex vivo study. Toxicol. In Vitro 2008, 22:910-920.
55. Poortman A.J., Lock E. Analytical profile of 4-methylthioamphetamine (4-MTA), a new street drug. Forensic Sci. Int. 1999, 100:221-233.
56. Quinton M.S., Yamamoto B.K. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J. 2006, 8:E337-347.
57. Riddles P.W., Blakeley R.L., Zerner B. Reassessment of Ellman's reagent. Methods Enzymol. 1983, 91:49-60.
58. Rusyniak D.E., Tandy S.L., Kamendulis L.M., Sprague J.E., Klaunig J.E. The effect of ecstasy (MDMA) on rat liver bioenergetics. Acad. Emerg. Med. 2004, 11:723-729.
59. Scatena R., Bottoni P., Botta G., Martorana G.E., Giardina B. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am. J. Physiol. Cell Physiol. 2007, 239:12-21.
60. Tatton W., Chalmers-Redman R., Tatton N. Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B. J. Neural Transm. 2003, 110:509-515.
61. Varela-Rey M., Montiel-Duarte C., Beitia G., Cenarruzabeitia E., Iraburu M.J. 3,4-methlyenedioxymethamphetamine (ecstasy) stimulates the expression of α1(I) procollagen mRNA in hepatic stellate cells. Biochem. Biophys. Res. Commun. 1999, 259:678-682.
62. Wallace K.B. Mitochondrial off targets of drug therapy. Trends Pharmacol. Sci. 2008, 29:361-366.
63. Winstock A.R., Wolf K., Ramsey J. 4-MTA: a new synthetic drug on the dance scene. Drug Alcohol Depend. 2002, 67:111-115.
64. Yamada Y., Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv. Drug Deliv. Rev. 2008, 60:1439-1462.